WO2010094210A1 - Preparation method of (4s,5r)-half-ester - Google Patents

Preparation method of (4s,5r)-half-ester Download PDF

Info

Publication number
WO2010094210A1
WO2010094210A1 PCT/CN2010/000188 CN2010000188W WO2010094210A1 WO 2010094210 A1 WO2010094210 A1 WO 2010094210A1 CN 2010000188 W CN2010000188 W CN 2010000188W WO 2010094210 A1 WO2010094210 A1 WO 2010094210A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
alcohol
catalyst
reaction
cyclic anhydride
Prior art date
Application number
PCT/CN2010/000188
Other languages
French (fr)
Chinese (zh)
Inventor
陈芬儿
熊非
Original Assignee
帝斯曼知识产权资产管理有限公司
复旦大学
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 帝斯曼知识产权资产管理有限公司, 复旦大学 filed Critical 帝斯曼知识产权资产管理有限公司
Priority to CN201080008405XA priority Critical patent/CN102325779A/en
Publication of WO2010094210A1 publication Critical patent/WO2010094210A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C07D453/04Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems having a quinolyl-4, a substituted quinolyl-4 or a alkylenedioxy-quinolyl-4 radical linked through only one carbon atom, attached in position 2, e.g. quinine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/048Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B01J2231/48Ring-opening reactions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/02Catalysts comprising hydrides, coordination complexes or organic compounds containing organic compounds or metal hydrides
    • B01J31/0234Nitrogen-, phosphorus-, arsenic- or antimony-containing compounds
    • B01J31/0235Nitrogen containing compounds
    • B01J31/0245Nitrogen containing compounds being derivatives of carboxylic or carbonic acids
    • B01J31/0247Imides, amides or imidates (R-C=NR(OR))

Definitions

  • the present invention belongs to the field of organic chemistry, and in particular provides a process for the preparation of a (4&5R)-halfester (I).
  • R 1 is hydrogen, ⁇ C 6 alkyl, phenyl, p-tolyl, 3,4-dimethylphenyl, 3,4-dimethoxyphenyl, 3, 4, 5-trimethyl Phenyl, 3, 4, 5-trimethoxyphenyl, p-chlorophenyl
  • Ar is phenyl, p-methoxyphenyl, 3,4-dimethylphenyl, 3,4-dimethoxy Phenyl, 3, 4, 5-trimethylphenyl, 3, 4, 5-trimethoxyphenyl, p-chlorophenyl, thienylphenyl, furyl or naphthyl
  • R 2 is CH 3 ⁇ 4 alkyl, C 3 ⁇ C 6 cycloalkyl, C 2 ⁇ C 6 alkenyl, aryl fluorenyl or aralkenyl.
  • (4S, 5R)-half ester (I) is an important intermediate for the synthesis of (+)-biotin (( + ) -Biotin, vitamin H).
  • Gerecke et al. (Helv Chim Acta, 1970, 53, 991) reported the reaction of cholesteryl as a chiral auxiliary with a cyclic anhydride ( ⁇ ) to form a diastereomeric cyclic acid half ester, which was isolated by recrystallization (4 & 5i?)-half ester (I); European Patent 92194 prepared (4S, 5i?)-half ester (I) by optically active substitution of chiral secondary alcohol and tert-butanol as chiral auxiliary agents; Sexual adjuvants are expensive, difficult to prepare, and inconvenient to recycle.
  • European Patent 84892 Chen Fener et al. Advanced Synthesis & Catalysis, 2005, 3 ⁇ 7, 549) respectively reported the stereoselective hydrolysis of internal diester diesters using pig liver esterase and polymerized pig liver esterase as catalysts.
  • the object of the present invention is to overcome the deficiencies of the prior art and to provide a method for preparing (4 & 5i?)-half ester (I) with mild reaction conditions, short time, high yield and high stereoselectivity.
  • the cyclic anhydride (II) is subjected to enantioselective ring-opening with an alcohol under the catalysis of a 9-equivalent sulfonamide catalyst (A) to obtain a 5?)-half ester (I total yield > 90%, ee >99%.
  • the synthetic route is as follows:
  • R 1 is hydrogen, C ⁇ fluorenyl, phenyl, p-tolyl, 3,4-dimethylphenyl, 3,4-dimethoxyphenyl, 3,4,5-trimethylbenzene , 3, 4, 5-trimethoxyphenyl, p-chlorophenyl, ⁇ : phenyl, p-methoxyphenyl, 3,4-dimethylphenyl, 3,4-dimethoxy Phenyl, 3, 4, 5-trimethylphenyl, 3, 4, 5-trimethoxyphenyl, p-chlorophenyl, thienylphenyl, furyl or naphthyl;
  • the catalyst is a 9-epiquine sulfonamide compound having a structure such as (A), which enables the reaction to be prepared at room temperature under high yield and high stereoselectivity. (4 & 5/?)-half ester (I), the method has a short reaction time, and the chiral catalyst (A) is convenient to synthesize, has a wide range of raw materials, and can be quantitatively recovered, and is suitable for industrial production.
  • the catalyst (A) (R 3 is ethyl, vinyl; R 4 is 3, 5-bistrifluoromethylphenyl; R 5 is -OR 6 , R 6 is a methyl group) is a known compound, and a synthesis method thereof is known in the art or synthesized according to a method known to a person skilled in the art.
  • the catalyst (A) (R 3 is ethyl, vinyl; R 4 is 4-trifluoromethylphenyl, 4-nitrophenyl, 3, 5 - bis nitrophenyl or cyclohexyl group; R 5 is -OR 6, R 6 is methyl) is a new synthesis of the compounds, their synthesis is known in the art or synthesized according to methods known to those skilled in the art.
  • R 3 is hydrogen, Ce alkyl, C 2 -C 6 alkenyl or C 2 -C 6 alkynyl
  • R 4 is hydrogen, d-C 6 alkyl, C 2 -C 6 alkenyl, C 2 ⁇ a C 6 alkynyl group, a C 3 -C 6 cycloalkyl group, an aryl group or a substituted derivative of any of the above groups
  • R 5 is -H or -OR 6
  • R 6 is a ⁇ C 6 alkyl group, a C 3 -C 6 ring
  • the alcohol used in the present invention is a ⁇ C 6 fatty alcohol, a C 3 -C 6 cycloalkyl alcohol, a C 2 -C 6 enol, an aralkyl alcohol, an aryl enol or an optionally substituted derivative of the above alcohol, such as: Methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, cyclohexanol, allyl alcohol, benzyl alcohol, cinnamyl alcohol and the like can be used for the asymmetric monoesterification reaction.
  • These alcohols are inexpensive and readily available, with a wide range of sources.
  • the organic solvent used is a halogenated hydrocarbon (such as dichloromethane, chloroform, 1,2-dichloroethane, carbon tetrachloride, etc.); an aliphatic hydrocarbon (such as hexanyl, heptane, octane, decane, acetonitrile, acetic acid) Ethyl esters, etc.; aromatic hydrocarbons (such as benzene, toluene, xylene, nitrobenzene, etc.); various halogenated aromatic hydrocarbons (such as chlorobenzene, etc.); ether solvents (such as diethyl ether, methyl tert-butyl ether, tetrahydrofuran) Or 1, 4-dioxane, etc.).
  • a halogenated hydrocarbon such as dichloromethane, chloroform, 1,2-dichloroethane, carbon tetrachloride, etc.
  • the molar ratio of the cyclic anhydride ( ⁇ ) / alcohol / chiral catalyst is 1: 1 ⁇ 10: 0.01 - 2.2, and the reaction can be successfully completed.
  • the reaction temperature is controlled between -20 ° C and 50 ° C, and the reaction time is controlled between 0.5 and 180 min. The reaction is completed.
  • R 3 is ethyl or vinyl; R 4 is 3, 5-bistrifluoromethylphenyl; R 5 is -OR 0 , and R 6 is
  • the methyl 9-epiquine sulfonamide catalyst is a preferred chiral catalyst, and the catalyst has the advantages of convenient synthesis, wide source of raw materials, and easy recovery.
  • the alcohol used is methanol, which is widely available and inexpensive.
  • the organic solvent used is preferably methyl tert-butyl ether (MTBE), which is environmentally friendly, widely available, and inexpensive.
  • MTBE methyl tert-butyl ether
  • the molar ratio of the cyclic anhydride ( ⁇ ) / alcohol / chiral catalyst is preferably 1:3 to 10:0.01 to 1.1.
  • the reaction temperature is preferably in the range of 0 to 25 °C.
  • the reaction time is preferably from 0.5 to 30 min.
  • the invention has the advantages of mild reaction condition, short reaction time, simple operation, easy availability of raw materials, high yield and high stereoselectivity of the obtained product, and the catalyst can be quantitatively recovered and applied, and the cost is low, and is suitable for industrial production. detailed description
  • Catalyst recovery The separated aqueous hydrochloric acid layer was adjusted to pH 14 with a 20% NaOH solution, and the precipitated white solid was filtered, and the catalyst was quantitatively recovered by drying.
  • the ring (0.5 L) was placed in a thousand dry reaction flask, and anhydrous methanol (40.4 mL, 1.0 mol) was added dropwise at 25 ° C, and stirring was continued for 5 min.
  • the tert-butyl ether (1 L) was placed in a dry reaction flask, and anhydrous methanol (40.4 mL, 1 mol) was added dropwise at 25 ° C and stirring was continued for 0.5 min.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

The method for preparing the (4S,5R)-half-ester which is the important intermediate of synthesizing the (+)-biotin is provided, which comprises  reacting cycloanhydride with alcohol through enantioselective ring opening reaction in the presence of 9-sulfonamide epiquinine catalyst to obtain (4S,5R)-half-ester(I). The materials of reaction are cheap and easy to obtain, the reaction time is short, the operation is simple and the catalyst can be quantificationally recovered. This method has high yield and enantioselectivity, and is suitable for industrial production.

Description

(4S, 5R)-半酯的制备方法 技术领域- 本发明属有机化学领域, 具体为提供一种 (4& 5R)-半酯 ( I ) 的制备方法。  TECHNICAL FIELD OF THE INVENTION The present invention belongs to the field of organic chemistry, and in particular provides a process for the preparation of a (4&5R)-halfester (I).
Figure imgf000002_0001
式中 R1为氢、 ~C6烷基、 苯基、 对甲苯基、 3, 4-二甲基苯基、 3, 4-二甲 氧基苯基、 3, 4, 5-三甲基苯基、 3, 4, 5-三甲氧基苯基、对氯苯基, Ar为苯基、 对甲氧基苯基、 3, 4-二甲基苯基、 3, 4-二甲氧基苯基、 3, 4, 5-三甲基苯基、 3, 4, 5-三甲氧基苯基、 对氯苯基、 噻吩基苯基、 呋喃基或者萘基; R2为 CH¾烷 基、 C3~C6环烷基、 C2~C6烯基、 芳垸基或芳烯基。 背景技术
Figure imgf000002_0001
Wherein R 1 is hydrogen, ~C 6 alkyl, phenyl, p-tolyl, 3,4-dimethylphenyl, 3,4-dimethoxyphenyl, 3, 4, 5-trimethyl Phenyl, 3, 4, 5-trimethoxyphenyl, p-chlorophenyl, Ar is phenyl, p-methoxyphenyl, 3,4-dimethylphenyl, 3,4-dimethoxy Phenyl, 3, 4, 5-trimethylphenyl, 3, 4, 5-trimethoxyphenyl, p-chlorophenyl, thienylphenyl, furyl or naphthyl; R 2 is CH 3⁄4 alkyl, C 3 ~ C 6 cycloalkyl, C 2 ~ C 6 alkenyl, aryl fluorenyl or aralkenyl. Background technique
(4S, 5R)-半酯 ( I )是合成 (+ ) -生物素 (( + ) -Biotin, 维生素 H) 的重 要中间体。  (4S, 5R)-half ester (I) is an important intermediate for the synthesis of (+)-biotin (( + ) -Biotin, vitamin H).
该化合物最早由 Gerecke等(He/v Chim Acta, 1970, 53, 991 )报道, 将环酸酐 ( II )与环己醇单酯化制成外消旋环酸单环己醇酯再与伪麻黄碱进行非对映体结 晶(direct enantiomorphous crystallization)拆分制备所需要的 (4 & 5i?)-半酯( I ); 此后德国专利 2058234、 中国专利 106365、欧洲专利 92194和陈芬儿等 高等学 校化学学报 , 2WS1, 12, U4V) 分别报道了用脱氢松香胺、 取代的手性二苯基乙胺 和氯霉素副产物 (IS, 2S) -苏式 对硝基苯基) -1, 3-丙二醇为拆分剂的方法制备 (4S, 5R)-半酯 ( I、。 遗憾的是以上方法均存在着单次拆分率低、 操作复杂、 成 本较高等拆分法的通病。 This compound was first reported by Gerecke et al. (He/v Chim Acta, 1970, 53, 991), which monoesterified cyclic anhydride (II) with cyclohexanol to form racemic cyclic acid monocyclohexanol ester and then pseudoephedrine. (4 & 5i?)-half ester (I) required for the preparation of direct enantiomorphous crystallization; thereafter German Patent 2058234, Chinese Patent 106365, European Patent 92194 and Chen Fener , 2WS1 , 12, U4V) reported by dehydroabietylamine, substituted chiral diphenylethylamine and chloramphenicol by-product (IS, 2S) - threo-p-nitrophenyl) -1, 3- The propylene glycol is a resolving agent for the preparation of (4S, 5R)-half esters (I.) Unfortunately, the above methods all have the common problems of splitting methods such as low single resolution, complicated operation and high cost.
Gerecke等 (Helv Chim Acta, 1970, 53, 991 )报道了以胆甾醇为手性辅助剂与 环酸酐 (Π ) 反应形成非对映异构体环酸半酯, 经重结晶分离得 (4 & 5i?)-半酯 ( I );欧洲专利 92194以光学活性取代手性仲醇和叔丁醇作为手性辅助剂制备了 (4S, 5i?)-半酯 ( I ) ; 但是以上方法均存在手性辅助剂价格昂贵、 制备困难和不 便回收等缺陷。  Gerecke et al. (Helv Chim Acta, 1970, 53, 991) reported the reaction of cholesteryl as a chiral auxiliary with a cyclic anhydride (Π) to form a diastereomeric cyclic acid half ester, which was isolated by recrystallization (4 & 5i?)-half ester (I); European Patent 92194 prepared (4S, 5i?)-half ester (I) by optically active substitution of chiral secondary alcohol and tert-butanol as chiral auxiliary agents; Sexual adjuvants are expensive, difficult to prepare, and inconvenient to recycle.
欧洲专利 84892、 陈芬儿等 Advanced Synthesis & Catalysis, 2005, 3^7, 549) 分别报道了以猪肝酯酶和聚合猪肝酯酶为催化剂对内消选二酯的立体选择性水 解的方法制备 (4 & 5i?)-半酯 ( I ); 中国专利 1473832、 101157655、 101279947分 别报道了以手性胺 (1& 25)-1-(4-硝基苯基) -2-N, N-二甲氨基 -3-三苯甲氧基 -1-丙 醇、 9-炔丙基奎宁、(1& 2 -3-三垸基硅氧基胺基醇为手性催化剂催化环酸酐( II ) 的不对称醇解制备(4 & 5i?)-半酯 ( I ) 的方法, 然而以上方法均对反应温度要 求苛刻, 不利于产业化生产。 European Patent 84892, Chen Fener et al. Advanced Synthesis & Catalysis, 2005, 3^7, 549) respectively reported the stereoselective hydrolysis of internal diester diesters using pig liver esterase and polymerized pig liver esterase as catalysts. Preparation of (4 & 5i?)-half esters (I); Chinese patents 1473832, 101157655, 101279947 reported the use of chiral amines (1 & 25)-1-(4-nitrophenyl)-2-N, N- Dimethylamino-3-trityloxy-1-propanol, 9-propargylquinine, (1& 2 -3-trimethylsilyloxyamino alcohol as a chiral catalyst for the catalyzed cyclic anhydride ( II ) Asymmetric alcoholysis to prepare (4 & 5i?)-half ester (I), however, all of the above methods are required for the reaction temperature Demanding harshness is not conducive to industrial production.
中国专利 101284832报道了以 9-表奎宁脲为手性催化剂在室温条件下高收率 和高选择性制备(4 & 5i?)-半酯 ( I ) 的方法, 该法虽然解决了不对称催化环酸 酐 (II ) 醇解对反应温度要求苛刻的缺陷, 但还是存在反应时间较长的缺陷。 发明内容  Chinese Patent 101284832 reports a method for preparing (4 & 5i?)-half ester (I) with high yield and high selectivity at room temperature with 9-equinic urea as a chiral catalyst, which solves the asymmetry The catalytic cyclic anhydride (II) alcoholysis has a severe defect on the reaction temperature, but there are still defects in the reaction time. Summary of the invention
本发明目的在于克服现有技术不足, 提供一种反应条件温和、 时间短, 高收 率和高立体选择性制备 (4 & 5i?)-半酯 ( I ) 的方法。  SUMMARY OF THE INVENTION The object of the present invention is to overcome the deficiencies of the prior art and to provide a method for preparing (4 & 5i?)-half ester (I) with mild reaction conditions, short time, high yield and high stereoselectivity.
本发明将环酸酐 (II )在 9-表奎宁磺酰胺催化剂(A) 的催化下与醇进行对 映选择性开环制得 5 ?)-半酯( I 总收率 >90 % , ee>99 %。其合成路线 如下:  In the present invention, the cyclic anhydride (II) is subjected to enantioselective ring-opening with an alcohol under the catalysis of a 9-equivalent sulfonamide catalyst (A) to obtain a 5?)-half ester (I total yield > 90%, ee >99%. The synthetic route is as follows:
Figure imgf000003_0001
Figure imgf000003_0001
式中 R1为氢、 C^ 垸基、 苯基、 对甲苯基、 3, 4-二甲基苯基、 3, 4-二甲 氧基苯基、 3, 4, 5-三甲基苯基、 3, 4, 5-三甲氧基苯基、 对氯苯基, Αι:为苯基、 对甲氧基苯基、 3, 4-二甲基苯基、 3, 4-二甲氧基苯基、 3, 4, 5-三甲基苯基、 3, 4, 5-三甲氧基苯基、对氯苯基、噻吩基苯基、呋喃基或者萘基;
Figure imgf000003_0002
Wherein R 1 is hydrogen, C^ fluorenyl, phenyl, p-tolyl, 3,4-dimethylphenyl, 3,4-dimethoxyphenyl, 3,4,5-trimethylbenzene , 3, 4, 5-trimethoxyphenyl, p-chlorophenyl, Αι: phenyl, p-methoxyphenyl, 3,4-dimethylphenyl, 3,4-dimethoxy Phenyl, 3, 4, 5-trimethylphenyl, 3, 4, 5-trimethoxyphenyl, p-chlorophenyl, thienylphenyl, furyl or naphthyl;
Figure imgf000003_0002
C3〜C6环烷基、 C2~C6烯基、 芳烷基或芳烯基。 C 3 -C 6 cycloalkyl, C 2 -C 6 alkenyl, aralkyl or aralkenyl.
在本发明的不对称单酯化中, 催化剂为结构如 (A)所示的 9-表奎宁磺酰胺 化合物, 它能使反应在室温的条件下, 高收率和高立体选择性的制备 (4 & 5/?)-半 酯 ( I ), 该方法反应时间短, 同时手性催化剂 (A)合成方便, 原料来源广泛, 并可定量回收, 适于产业化生产。  In the asymmetric monoesterification of the present invention, the catalyst is a 9-epiquine sulfonamide compound having a structure such as (A), which enables the reaction to be prepared at room temperature under high yield and high stereoselectivity. (4 & 5/?)-half ester (I), the method has a short reaction time, and the chiral catalyst (A) is convenient to synthesize, has a wide range of raw materials, and can be quantitatively recovered, and is suitable for industrial production.
在本发明的某些具体实施方式中, 所述的催化剂(A) (R3为乙基、 乙烯基; R4为 3, 5-双三氟甲基苯基; R5为 -OR6, R6为甲基) 为已知化合物, 其合成方法 在本领域是已知的或者根据本领域技术人员公知的方法合成。 In some embodiments of the invention, the catalyst (A) (R 3 is ethyl, vinyl; R 4 is 3, 5-bistrifluoromethylphenyl; R 5 is -OR 6 , R 6 is a methyl group) is a known compound, and a synthesis method thereof is known in the art or synthesized according to a method known to a person skilled in the art.
在本发明的某些具体实施方式中, 所述的催化剂(A) (R3为乙基、 乙烯基; R4为 4-三氟甲基苯基、 4-硝基苯基、 3, 5-双硝基苯基或环己基; R5为 -OR6, R6 为甲基)为新合成化合物,其合成方法在本领域是已知的或者根据本领域技术人 员公知的方法合成。 In some embodiments of the invention, the catalyst (A) (R 3 is ethyl, vinyl; R 4 is 4-trifluoromethylphenyl, 4-nitrophenyl, 3, 5 - bis nitrophenyl or cyclohexyl group; R 5 is -OR 6, R 6 is methyl) is a new synthesis of the compounds, their synthesis is known in the art or synthesized according to methods known to those skilled in the art.
Figure imgf000004_0001
Figure imgf000004_0001
式中 R3为氢、 Ce烷基、 C2~C6烯基或 C2~C6炔基; R4为氢、 d~C6烷基、 C2~C6烯基、 C2~C6炔基、 C3~C6环烷基、 芳基或任何上述基的取代衍生物; R5 为 -H或 -OR6, R6为 ~C6烷基、 C3〜C6环烷基、 C2~C6烯基、 C2~C6酰基、苄基、 苯甲酰基、 肉桂基或任何上述基的取代衍生物。 Wherein R 3 is hydrogen, Ce alkyl, C 2 -C 6 alkenyl or C 2 -C 6 alkynyl; R 4 is hydrogen, d-C 6 alkyl, C 2 -C 6 alkenyl, C 2 ~ a C 6 alkynyl group, a C 3 -C 6 cycloalkyl group, an aryl group or a substituted derivative of any of the above groups; R 5 is -H or -OR 6 , and R 6 is a ~C 6 alkyl group, a C 3 -C 6 ring An alkyl group, a C 2 -C 6 alkenyl group, a C 2 -C 6 acyl group, a benzyl group, a benzoyl group, a cinnamyl group or a substituted derivative of any of the above groups.
本发明所用的醇为 〜C6脂肪醇、 C3~C6环烷基醇、 C2~C6烯醇、 芳烷醇、 芳基烯醇或上述醇的任选取代衍生物, 如: 甲醇、 乙醇、 正丙醇、 异丙醇、 正丁 醇、 异丁醇、 环己醇、 烯丙醇、 苄醇、 肉桂醇等, 均可用于不对称单酯化反应。 这些醇价廉易得, 来源广泛。 所用有机溶剂有卤代烃(如二氯甲烷、 氯仿、 1, 2- 二氯乙烷、 四氯化碳等); 脂肪烃(如己垸、 庚烷、 辛垸、 壬烷、 乙腈、 乙酸乙 酯等); 芳香烃 (如苯、 甲苯、二甲苯、 硝基苯等); 各种卤代芳香烃(如氯苯等); 醚类溶剂(如乙醚、 甲基叔丁基醚、 四氢呋喃或 1, 4-二氧六环等)。这些溶剂来 源广泛,价廉易得,便于回收。环酸酐( Π ) /醇 /手性催化剂的摩尔比为 1: 1〜10: 0.01 - 2.2, 反应即可顺利完成。 反应温度控制在 -20 °C ~ 50 °C, 反应时间控制在 0.5〜180 min之间, 反应即可完成。 The alcohol used in the present invention is a ~C 6 fatty alcohol, a C 3 -C 6 cycloalkyl alcohol, a C 2 -C 6 enol, an aralkyl alcohol, an aryl enol or an optionally substituted derivative of the above alcohol, such as: Methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, cyclohexanol, allyl alcohol, benzyl alcohol, cinnamyl alcohol and the like can be used for the asymmetric monoesterification reaction. These alcohols are inexpensive and readily available, with a wide range of sources. The organic solvent used is a halogenated hydrocarbon (such as dichloromethane, chloroform, 1,2-dichloroethane, carbon tetrachloride, etc.); an aliphatic hydrocarbon (such as hexanyl, heptane, octane, decane, acetonitrile, acetic acid) Ethyl esters, etc.; aromatic hydrocarbons (such as benzene, toluene, xylene, nitrobenzene, etc.); various halogenated aromatic hydrocarbons (such as chlorobenzene, etc.); ether solvents (such as diethyl ether, methyl tert-butyl ether, tetrahydrofuran) Or 1, 4-dioxane, etc.). These solvents come from a wide range of sources, are inexpensive and readily available, and are easy to recycle. The molar ratio of the cyclic anhydride ( Π ) / alcohol / chiral catalyst is 1: 1~10: 0.01 - 2.2, and the reaction can be successfully completed. The reaction temperature is controlled between -20 ° C and 50 ° C, and the reaction time is controlled between 0.5 and 180 min. The reaction is completed.
本发明中, 9-表奎宁磺酰胺催化剂 (A) 中 R3为乙基、 乙烯基; R4为 3, 5- 双三氟甲基苯基; R5为 -OR0, R6为甲基的 9-表奎宁磺酰胺催化剂为优选的手性 催化剂, 此催化剂具有合成方便, 原料来源广泛, 易于回收等优点。 In the present invention, in the 9-epiquinine sulfonamide catalyst (A), R 3 is ethyl or vinyl; R 4 is 3, 5-bistrifluoromethylphenyl; R 5 is -OR 0 , and R 6 is The methyl 9-epiquine sulfonamide catalyst is a preferred chiral catalyst, and the catalyst has the advantages of convenient synthesis, wide source of raw materials, and easy recovery.
本发明中, 所用的醇为甲醇, 来源广泛、 价格低廉。  In the present invention, the alcohol used is methanol, which is widely available and inexpensive.
本发明中, 所用有机溶剂优选为甲基叔丁基醚(MTBE), 环境友好、来源广 泛、 价格低廉。  In the present invention, the organic solvent used is preferably methyl tert-butyl ether (MTBE), which is environmentally friendly, widely available, and inexpensive.
本发明中, 环酸酐 (Π ) /醇 /手性催化剂的摩尔比优选为 1:3~10:0.01~1.1。 本发明中, 反应温度优选在 0~25°C范围。  In the present invention, the molar ratio of the cyclic anhydride (Π) / alcohol / chiral catalyst is preferably 1:3 to 10:0.01 to 1.1. In the present invention, the reaction temperature is preferably in the range of 0 to 25 °C.
本发明中, 反应时间优选在 0.5~30min。  In the present invention, the reaction time is preferably from 0.5 to 30 min.
本发明具有反应条件温和、 反应时间短、 操作简便、 原料价廉易得, 所得产 物具有高收率和高立体选择性, 并且催化剂可定量回收套用, 成本低, 适于产业 化生产。 具体实施方式  The invention has the advantages of mild reaction condition, short reaction time, simple operation, easy availability of raw materials, high yield and high stereoselectivity of the obtained product, and the catalyst can be quantitatively recovered and applied, and the cost is low, and is suitable for industrial production. detailed description
下述实施方式更好地说明本发明内容,但本领域技术人员可以理解的是限定 本发明范围的是本发明的权利要求, 并不限于下述实施例。 The following embodiments better illustrate the contents of the present invention, but those skilled in the art will understand that the definition is limited. The scope of the present invention is the claims of the present invention, and is not limited to the embodiments described below.
实施例 1 将顺 -1, 3-二苄基咪唑啉 -2-酮 -2H-呋喃并 [3, 4-d]P米唑 -2, 4, 6-三酮 (33.6 g, 0·10 ιηο1)、 催化剂 A (R3=-CH=CH2; R4=3,5-(CF3)2C6H3 ; R5=-OR6, R6=CH3 ) (6.0 g, 0.01 mol), 甲基叔丁基醚(1 L)置于一干燥反应瓶中,于 25 °C 滴加无水甲醇 (40.4 mL, 1 mol) 后持续搅拌 5 min。 反应毕, 向剩余物中加入 2M盐酸 (400 mL)搅拌 ΙΟ ηώι, 静置, 分出有机层, 无水硫酸钠干燥。 过滤, 滤液减压回收溶剂得到白色结晶性粉末 I O^—H, Ax Ph, R2= -CH3, 34.2 g, 93 %), mpl49~150 °C , [a]D 22=+2.74° (c 0.20, CHC13 ) Example 1 cis-1,3-dibenzylimidazolidin-2-one-2H-furo[3,4-d]Pmazole-2,4,6-trione (33.6 g, 0·10) Ιηο1), Catalyst A (R 3 =-CH=CH 2 ; R 4 =3,5-(CF 3 ) 2 C 6 H 3 ; R 5 =-OR 6 , R 6 =CH 3 ) (6.0 g, 0.01 Mol), methyl tert-butyl ether (1 L) was placed in a dry reaction flask, and anhydrous methanol (40.4 mL, 1 mol) was added dropwise at 25 ° C and stirring was continued for 5 min. After the completion of the reaction, 2M hydrochloric acid (400 mL) was added to the residue, and the mixture was stirred and evaporated to dryness. Filtration, the filtrate was evaporated under reduced pressure to give a white crystalline powder IO--H, Ax Ph, R 2 = -CH 3 , 34.2 g, 93 %), mpl 49 to 150 ° C, [a] D 22 = +2.74 ° ( c 0.20, CHC1 3 )
IR (KBr) : v=2979, 2384, 2281 , 1742, 1463 , 1229, 1169, 767cm"1. IR (KBr) : v=2979, 2384, 2281, 1742, 1463, 1229, 1169, 767cm" 1 .
1H NMR ( CDC13) :5=3.54 (s, 1H, OC¾), 4.00-4.04 (m, 2H, C6a-H, C3a-H) , 4.16-4.80 (dddd, 4H, 2xCH2C6H5) , 7.19-7.53 (m, 10H, 2xArH) ppm. 1H NMR (CDC1 3 ): 5=3.54 (s, 1H, OC3⁄4), 4.00-4.04 (m, 2H, C 6a -H, C 3a -H) , 4.16-4.80 (dddd, 4H, 2xCH 2 C 6 H 5 ) , 7.19-7.53 (m, 10H, 2xArH) ppm.
EI-MS: (m/z, %) =368 (M+, 37), 323 (46), 309 ( 59), 265 (44), 154 ( 8), 136 ( 18), 91 ( 100) . EI-MS: (m/z, %) = 368 (M+, 37), 323 (46), 309 (59), 265 (44), 154 (8), 136 (18), 91 (100) .
催化剂的回收: 将分出的盐酸水溶液层用 20% NaOH溶液调节 pH至 14, 将析 出的白色固体过滤, 干燥即可定量回收催化剂。 Catalyst recovery: The separated aqueous hydrochloric acid layer was adjusted to pH 14 with a 20% NaOH solution, and the precipitated white solid was filtered, and the catalyst was quantitatively recovered by drying.
实施例 2 将顺 -1, 3-二苄基咪唑啉 -2-酮 -2H-呋喃并 [3, 4-d]咪唑 -2, 4, 6—三 酮(33.6 g, 0.10 mol),催化剂 A (R3=-CH=CH2; R4=3,5-(N02)2C6H3; R5=-OR6, R6=CH3 ) ( 5.8 g, 0.01 mol), 1, 4-二氧六环 ( 1 L)置于一干燥反应瓶中,于 25。C 滴加丙炔醇(58.2 mL, 1 mol)后持续搅拌 5 min。 反应毕, 向剩余物中加入 2 M 盐酸(40 mL)搅拌 10 min, 静置, 分出有机层, 无水硫酸钠干燥。 过滤, 滤液 减压回收溶剂, 得白色结晶性粉末 I 一 H, Ax= -Ph, R2=propargyl, 37.2g, 95%) , mpl32.7~135.8 °C, [a]D 25=+14.3° (c 1.0, CHC13)。 Example 2 cis-1,3-dibenzylimidazolidin-2-one-2H-furo[3,4-d]imidazole-2,4,6-trione (33.6 g, 0.10 mol), catalyst A (R 3 =-CH=CH 2 ; R 4 =3,5-(N0 2 ) 2 C 6 H 3 ; R 5 =-OR 6 , R 6 =CH 3 ) (5.8 g, 0.01 mol), 1 4-Dioxane (1 L) was placed in a dry reaction flask at 25. C Add propargyl alcohol (58.2 mL, 1 mol) and stir for 5 min. After completion of the reaction, 2 M hydrochloric acid (40 mL) was added to the residue and the mixture was stirred for 10 min, and the organic layer was separated and dried over anhydrous sodium sulfate. Filtration, the filtrate was evaporated under reduced pressure to give a white crystalline powder I-H, Ax= -Ph, R 2 =propargyl, 37.2 g, 95%), mpl32.7~135.8 °C, [a] D 25 = +14.3 ° (c 1.0, CHC1 3 ).
实施例 3 将顺 -1, 3-二苄基咪唑啉 -2-酮 -2H-呋喃并 [3, 4-d]咪唑 -2, 4, 6-三酮 (33.6 g, 0.10 mol)、催化剂 A (R3=-CH=CH2; R4=2-N02C6H4; R5=-OR66=CH3 ) ( 5.1 g, 0.01 mol), 1, 4-二氧六环 (0.5 L)置于一千燥反应瓶中, 于 25°C滴加 无水甲醇(40.4 mL, 1.0 mol)后持续搅拌 5 min。 反应毕, 向剩余物中加入 2 M 盐酸(400 mL)搅拌 lOmin, 静置, 分出有机层, 无水硫酸钠干燥。 过滤, 滤液 减压回收溶剂, 得白色结晶性粉末 I U^—H, Ax=—Ph, R2^ -CH3, 33.2 g, 90%) , mpl48~150°C , [o;]D 22=+2.70。(c 0.20, CHC13)。 Example 3 cis-1,3-dibenzylimidazolidin-2-one-2H-furo[3,4-d]imidazole-2,4,6-trione (33.6 g, 0.10 mol), catalyst A (R 3 =-CH=CH 2 ; R 4 =2-N0 2 C 6 H 4 ; R 5 =-OR 6 , 6 =CH 3 ) ( 5.1 g, 0.01 mol), 1, 4-dioxane The ring (0.5 L) was placed in a thousand dry reaction flask, and anhydrous methanol (40.4 mL, 1.0 mol) was added dropwise at 25 ° C, and stirring was continued for 5 min. After completion of the reaction, 2 M hydrochloric acid (400 mL) was added to the residue, and the mixture was stirred for 10 min, and the organic layer was separated and dried over anhydrous sodium sulfate. Filtration, the filtrate was evaporated under reduced pressure to give white crystalline powder IU^-H, Ax=-Ph, R 2 ^ -CH 3 , 33.2 g, 90%), mpl 48-150 ° C, [o;] D 22 = +2.70. (c 0.20, CHC1 3 ).
实施例 4 将顺 -1, 3-二苄基咪唑啉 -2-酮 -2H-呋喃并 [3, 4-d]咪唑 -2, 4, 6-三酮 (33.6 g, 0.10 mol)、催化剂 A (R3=-CH=C¾; R4=4-FC6H4; R5=-OR6, R6=CH3 ) (4.8 g, 0.01 mol), 四氢呋喃 (0.5 L) 置于一干燥反应瓶中, 于 25 °C下滴加无 水甲醇(40.4 mL, 1.0 mol)后持续搅拌 24小时。 反应毕, 向剩余物中加入 2 M 盐酸 (400 mL) 搅拌 10 min, 静置, 分出有机层, 无水硫酸钠干燥。 过滤, 滤 液减压回收溶剂,得白色结晶性粉末 I — H, Ax=—Ph, R2= -CH3, 33.5 g, 91%), mpl47~150 °C, [a]D =+2.70° (c0.20, CHC13)。 Example 4 cis-1,3-dibenzylimidazolidin-2-one-2H-furo[3,4-d]imidazole-2,4,6-trione (33.6 g, 0.10 mol), catalyst A (R 3 =-CH=C3⁄4; R 4 =4-FC 6 H 4 ; R 5 =-OR 6 , R 6 =CH 3 ) (4.8 g, 0.01 mol), tetrahydrofuran (0.5 L) placed in a dry In the reaction flask, anhydrous methanol (40.4 mL, 1.0 mol) was added dropwise at 25 ° C, and stirring was continued for 24 hours. After completion of the reaction, 2 M hydrochloric acid (400 mL) was added to the residue and stirred for 10 min. Filtration, the filtrate was evaporated under reduced pressure to give a white crystalline powder I-H, Ax=-Ph, R 2 = -CH 3 , 33.5 g, 91%), mpl47~150 °C, [a] D = +2.70° (c0.20, CHC1 3 ).
实施例 5将顺 -1, 3-二苄基咪唑啉 -2-酮 -2H-呋喃并 [3, 4-d]咪唑 -2, 4, 6-三酮 (33.6 g, 0.10mol)、 催化剂 A (R3=-CH=CH2; R=3,5-(CF3)2C6H3; R5=-O 6, R6=CH3) (66.0 g, 0.11 mol)、甲基叔丁基醚(1 L)置于一干燥反应瓶中,于 25°C 滴加无水甲醇(40.4 mL, lmol)后持续搅拌 0.5min。 反应毕, 向剩余物中加入 2M盐酸(400mL)搅拌 lOmin, 静置, 分出有机层, 无水硫酸钠干燥。 过滤, 滤液减压回收溶剂得到白色结晶性粉末 I {R^-H, Ax=—Ph, R2=-CHs, 33.0 g, 90%), mpl49~150 °C, [a]D 22=+2.74° (c0.20, CHC13)。 Example 5 cis-1,3-dibenzylimidazolidin-2-one-2H-furo[3,4-d]imidazole-2,4,6-trione (33.6 g, 0.10 mol), catalyst A (R 3 =-CH=CH 2 ; R=3,5-(CF 3 ) 2 C 6 H 3 ; R 5 =-O 6 , R 6 =CH 3 ) (66.0 g, 0.11 mol), methyl The tert-butyl ether (1 L) was placed in a dry reaction flask, and anhydrous methanol (40.4 mL, 1 mol) was added dropwise at 25 ° C and stirring was continued for 0.5 min. After the reaction was completed, 2M hydrochloric acid (400 mL) was added to the residue, and the mixture was stirred for 10 min, and the organic layer was separated and dried over anhydrous sodium sulfate. The filtrate solvent was recovered under reduced pressure to give a white crystalline powder I {R ^ -H, Ax = -Ph, R 2 = -CHs, 33.0 g, 90%), mpl49 ~ 150 ° C, [a] D 22 = + 2.74° (c0.20, CHC1 3 ).

Claims

权 利 要 求 书 Claim
1、 (4 & 5 ?)-半酯 ( I ) 的制备方法-1, (4 & 5 ?)-half ester (I) preparation method -
R1 9 R1 R 1 9 R 1
Ar" 、Ν' N' 、Ar  Ar", Ν' N', Ar
H 〉 (-H  H 〉 (-H
R202C C02H R 2 0 2 C C0 2 H
( I ) 其特征在于环酸酐 ( II )在 9-表奎宁磺酰胺催化剂 (A) 的存在下与醇进行 对映选择性开环制得 (4 & 5 ?)-半酯 ( I ):  (I) characterized in that the cyclic anhydride (II) is subjected to enantioselective ring opening with an alcohol in the presence of a 9-epiquinine sulfonamide catalyst (A) to obtain a (4 & 5 ?)-halfester (I):
Figure imgf000007_0001
Figure imgf000007_0001
( II )  (II)
式中 R1为氢、 ~C6垸基、 苯基、 对甲苯基、 3, 4-二甲基苯基、 3 , 4-二甲 氧基苯基、 3, 4, 5-三甲基苯基、 3, 4, 5-三甲氧基苯基、 对氯苯基, Ar为苯基、 对甲氧基苯基、 3, 4-二甲基苯基、 3, 4-二甲氧基苯基、 3, 4, 5-三甲基苯基、 3, 4, 5-三甲氧基苯基、 对氯苯基、 噻吩基苯基、 呋喃基或者萘基; R2为 d~C6烷 基、 C3〜C6环烷基、 C2〜C6烯基、 芳垸基或芳烯基; Wherein R 1 is hydrogen, ~C 6 fluorenyl, phenyl, p-tolyl, 3,4-dimethylphenyl, 3,4-dimethoxyphenyl, 3, 4, 5-trimethyl Phenyl, 3,4,5-trimethoxyphenyl, p-chlorophenyl, Ar is phenyl, p-methoxyphenyl, 3,4-dimethylphenyl, 3,4-dimethoxy Phenyl, 3, 4, 5-trimethylphenyl, 3, 4, 5-trimethoxyphenyl, p-chlorophenyl, thienylphenyl, furyl or naphthyl; R 2 is d~C 6 An alkyl group, a C 3 ~C 6 cycloalkyl group, a C 2 ~C 6 alkenyl group, an aryl fluorenyl group or an arylalkenyl group;
所述的 9-表奎宁磺酰胺催化剂结构如 A所示:  The structure of the 9-epiquine sulfonamide catalyst is as shown in A:
Figure imgf000007_0002
Figure imgf000007_0002
A  A
式中 R3为氢、 C^ 烷基、 C2~C6烯基或 C2〜C6炔基; R4为氢、 ~C6烷基、 C2〜C6烯基、 C2~C6炔基、 C3~C6环垸基、 芳基或任何上述基的取代衍生物; R5 为 -H或 -OR6, R6为 Q~C6烷基、 C3~C6环垸基、 C2~C6烯基、 C2~C6酰基、 苄基、 苯甲酰基、 肉桂基或任何上述基的取代衍生物; 以及 Wherein R 3 is hydrogen, C^alkyl, C 2 -C 6 alkenyl or C 2 ~C6 alkynyl; R 4 is hydrogen, ~C 6 alkyl, C 2 ~C 6 alkenyl, C 2 ~C 6 alkynyl, substituted derivatives of C 3 ~ C 6 cycloalkyl embankment group, an aryl group or a group of any of the above; R 5 is -H or -OR 6, R 6 is Q ~ C 6 alkyl group, C 3 ~ C 6 cycloalkyl a mercapto group, a C 2 -C 6 alkenyl group, a C 2 -C 6 acyl group, a benzyl group, a benzoyl group, a cinnamyl group or a substituted derivative of any of the above groups;
所述的醇为 脂肪醇、 C3~C6环烷基醇、 C2~C6烯醇、 芳烷醇、 芳基烯 醇或上述醇的任选取代衍生物。 The alcohol is a fatty alcohol, a C 3 -C 6 cycloalkyl alcohol, a C 2 -C 6 enol, an aralkyl alcohol, an aryl enol or an optionally substituted derivative of the above alcohol.
2、如权利要求 1所述的方法, 其特征在于所述的环酸酐( II ) /醇 /手性催化 剂的摩尔比例为 1 : 1〜10: 0.01〜2.2;反应温度为 -20°C〜50 °C ;反应时间是 0.5〜 The method of claim 1 wherein said cyclic anhydride (II) / alcohol / chiral catalysis The molar ratio of the agent is 1: 1~10: 0.01~2.2; the reaction temperature is -20 ° C ~ 50 ° C; the reaction time is 0.5 ~
3、 如权利要求 1 所述的方法, 其特征在于所用的醇为甲醇、 烯丙醇、 环己 醇、 苄醇或肉桂醇。 3. Process according to claim 1, characterized in that the alcohol used is methanol, allyl alcohol, cyclohexanol, benzyl alcohol or cinnamyl alcohol.
4、 如权利要求 1所述的方法, 其特征在于所述有机溶剂为卤代烃、 脂肪烃、 芳香烃或醚类溶剂中的一种或几种。  4. The method according to claim 1, wherein the organic solvent is one or more of a halogenated hydrocarbon, an aliphatic hydrocarbon, an aromatic hydrocarbon or an ether solvent.
5、 如权利要求 4所述的方法, 其特征在于所述有机溶剂为甲苯、 乙醚、 甲 基叔丁基醚、 四氢呋喃、 1, 4-二氧六环。  The method according to claim 4, wherein the organic solvent is toluene, diethyl ether, methyl tert-butyl ether, tetrahydrofuran, 1,4-dioxane.
6、 如权利要求 1所述的方法, 其特征在于环酸酐(II ) /醇 /手性催化剂的摩 尔比为 1 : 3-10: 0.01~1.1。  The method according to claim 1, wherein the cyclic anhydride (II) / alcohol / chiral catalyst has a molar ratio of from 1:3 to 10: 0.01 to 1.1.
7、 如权利要求 1 所述的方法, 其特征在于由环酸酐 (II )制备半酯 ( I ) 时的反应温度为 0〜25 °C。  7. Process according to claim 1, characterized in that the reaction temperature for the preparation of the half ester (I) from the cyclic anhydride (II) is from 0 to 25 °C.
8、 如权利要求 1所述的方法, 其特征在于由环酸酐 (Π )制备半酯 ( I ) 时的反应时间为 0.5~30 min。  8. Process according to claim 1, characterized in that the reaction time for the preparation of the half ester (I) from the cyclic anhydride (?) is from 0.5 to 30 min.
9、如权利要求 1所述的方法,其特征在于所用的 9表奎宁磺酰胺催化剂(A) 中 R3为乙基、 乙烯基; R4为芳基及其衍生物; R5为 -OR6, R6为甲基。 The method according to claim 1, wherein R 3 of the quinidine sulfonamide catalyst (A) used is ethyl or vinyl; R 4 is an aryl group and a derivative thereof; and R 5 is - OR 6 and R 6 are methyl groups.
10、 如权利要求 9所述的方法, 其特征在于 R4为 3, 5-双三氟甲基苯基、 4- 三氟甲基苯基、 4-硝基苯基、 3, 5-双硝基苯基或环己基。 10. The method of claim 9, wherein R 4 is 3, 5-bistrifluoromethylphenyl, 4-trifluoromethylphenyl, 4-nitrophenyl, 3, 5-double Nitrophenyl or cyclohexyl.
11、 如权利要求 1所述的方法, 其特征在于该反应在有机溶剂中于常温, 常 压、 加压或者减压的状态下进行。  The method according to claim 1, wherein the reaction is carried out in an organic solvent at a normal temperature, under normal pressure, under pressure or under reduced pressure.
PCT/CN2010/000188 2009-02-18 2010-02-11 Preparation method of (4s,5r)-half-ester WO2010094210A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201080008405XA CN102325779A (en) 2009-02-18 2010-02-11 (4S, 5R)-preparation method of half ester

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN200910009332 2009-02-18
CN200910009332.5 2009-02-18

Publications (1)

Publication Number Publication Date
WO2010094210A1 true WO2010094210A1 (en) 2010-08-26

Family

ID=42633429

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2010/000188 WO2010094210A1 (en) 2009-02-18 2010-02-11 Preparation method of (4s,5r)-half-ester

Country Status (2)

Country Link
CN (1) CN102325779A (en)
WO (1) WO2010094210A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107686488A (en) * 2016-08-05 2018-02-13 浙江医药股份有限公司新昌制药厂 A kind of synthetic method of biotin intermediate

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313247B1 (en) * 1996-06-05 2001-11-06 Wolfgang Lindner Cinchonan based chiral selectors for separation of stereoisomers
CN101157655A (en) * 2007-09-20 2008-04-09 复旦大学 Method for synthesizing (4S,5R)- half-ester
CN101284832A (en) * 2008-06-05 2008-10-15 复旦大学 Preparation method of (4S, 5R)- half-ester

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1183137C (en) * 2003-04-16 2005-01-05 复旦大学 Synthesis method of [3aS, 6aR]-1,3-dibenzyl-tetrahydro-4H-fruo [3,4-d]-imidazolyl-2,4 [1H]-diketone [I]
EP1638677A4 (en) * 2003-06-11 2007-10-10 Univ Brandeis Catalytic asymmetric desymmetrization of prochiral and meso cyclic anhydrides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6313247B1 (en) * 1996-06-05 2001-11-06 Wolfgang Lindner Cinchonan based chiral selectors for separation of stereoisomers
CN101157655A (en) * 2007-09-20 2008-04-09 复旦大学 Method for synthesizing (4S,5R)- half-ester
CN101284832A (en) * 2008-06-05 2008-10-15 复旦大学 Preparation method of (4S, 5R)- half-ester

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
OH, SANG HO ET AL.: "A Highly reactive and enantioselective bifunctional organocatalyst for the methanolytic desymmetrization of cyclic anhydrides: prevention of catalyst aggregation", ANGEWANDTE CHEMIE, INTERNATIONAL EDITION, vol. 47, no. 41, 2008, pages 7872 - 7875 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107686488A (en) * 2016-08-05 2018-02-13 浙江医药股份有限公司新昌制药厂 A kind of synthetic method of biotin intermediate

Also Published As

Publication number Publication date
CN102325779A (en) 2012-01-18

Similar Documents

Publication Publication Date Title
Jiang et al. Highly enantioselective construction of a quaternary carbon center of dihydroquinazoline by asymmetric Mannich reaction and chiral recognition
Davies et al. Evaluating β-amino acids as enantioselective organocatalysts of the Hajos–Parrish–Eder–Sauer–Wiechert reaction
Hasegawa et al. Synthesis of α-Diazo-β-hydroxyesters through a one-pot protocol by phase-transfer catalysis: application to enantioselective aldol-type reaction and diastereoselective synthesis of α-amino-β-hydroxyester derivatives
WO2009046624A1 (en) Preparation methods of (4s,5r)-semi-esters
Tavakoli-Hoseini et al. Brønsted acidic ionic liquids as efficient catalysts for clean synthesis of carbamatoalkyl naphthols
Goudedranche et al. A temporary-bridge strategy for enantioselective organocatalyzed synthesis of aza-seven-membered rings
JP4301757B2 (en) Method for producing enantiomerically enriched N-acylated β-amino acid, method for producing β-amino acid by protecting group separation and use thereof
CN111269132A (en) Method for preparing chiral β -trifluoromethyl- β -hydroxy- α -amino acid and derivative thereof
Gao et al. Dynamic Kinetic Resolution of α-Trifluoromethyl Hemiaminals without α-Hydrogen via NHC-Catalyzed O-Acylation
CN107501112A (en) A kind of Chiral Synthesis of chiral beta amino acids and the synthetic method of medicine intermediate
Kano et al. Catalyst-controlled diastereoselectivity reversal in the formation of dihydropyrans
Yang et al. Dinuclear zinc-catalyzed asymmetric [3+ 2] cyclization reaction for direct assembly of chiral α-amino-γ-butyrolactones bearing three stereocenters
Xiong et al. Enantioselective synthesis of chiral multicyclic γ-lactones via dynamic kinetic resolution of racemic γ-keto carboxylic acids
JP2000053593A (en) Enantio-selective hydrogenation of ester compound and acid compound in presence of homogeneous catalyst, and use of hydrogenation product
CN104557583B (en) A kind of method synthesizing γ-aminobutyric acid class chipal compounds
AU2016232270A1 (en) Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile
WO2010094210A1 (en) Preparation method of (4s,5r)-half-ester
WO2021045879A1 (en) Synthesis of deuterated aldehydes
Weseliński et al. The asymmetric organocatalytic 1, 3-dipolar cycloaddition of alkyl pyruvate-derived nitrones and α, β-unsaturated aldehydes
CN114315609B (en) Technological method for preparing cis-2-aminocyclohexanol
CN114478424B (en) Preparation method of azlactone derivative with cycloalkenyl substituted at beta position
CN107497485B (en) Water-phase asymmetric Aldol reaction catalyst and preparation method and application thereof
CN101284832A (en) Preparation method of (4S, 5R)- half-ester
JP2011523654A (en) Method for preparing (4S, 5R) -half ester
Yi et al. Palladium-catalyzed asymmetric [3+ 4] cycloadditions for the construction of cyclohepta [b] indoles

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 201080008405.X

Country of ref document: CN

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10743391

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10743391

Country of ref document: EP

Kind code of ref document: A1